Does Priority Health Cover Cialis?

What Is Cialis and Why Does the Indication Matter for Coverage?

Cialis is the brand name for tadalafil, a phosphodiesterase type 5 (PDE5) inhibitor approved by the FDA in 2003 for erectile dysfunction (ED) and later for benign prostatic hyperplasia (BPH) in 2011 (FDA drug label, tadalafil). The reason indication matters is straightforward: insurance plans treat ED as a "lifestyle" condition in many states, meaning they can legally exclude it from formularies without violating essential health benefit rules. BPH, by contrast, is a medical condition with no such exclusion carve-out, so coverage approval rates are higher for that indication.

FDA-Approved Indications for Tadalafil

Tadalafil carries three distinct FDA-approved indications, each relevant to different coverage pathways:

1. Erectile dysfunction (on-demand 10 mg or 20 mg; or daily 2.5 mg or 5 mg)
2. Benign prostatic hyperplasia (daily 5 mg)
3. Pulmonary arterial hypertension (40 mg daily as Adcirca brand; covered under very different rules)

The prescribing physician's documented diagnosis code on the prescription directly influences whether Priority Health applies its ED exclusion or routes the claim through standard formulary processing. A prescription written for BPH (ICD-10: N40.1) is not subject to the same exclusion as one written for ED (ICD-10: N52.9) (NIH, Merck Manual on BPH pharmacotherapy).

How PDE5 Inhibitors Work

Tadalafil inhibits the PDE5 enzyme, preventing degradation of cyclic GMP in smooth muscle. This relaxes arterial walls in penile tissue and in the prostate/bladder neck, which explains its dual utility for ED and BPH (NCBI, mechanism of PDE5 inhibitors). The half-life of tadalafil is approximately 17.5 hours, the longest among approved PDE5 inhibitors, enabling the daily low-dose regimen that many patients prefer (FDA pharmacokinetics summary).

How Priority Health Structures Its Drug Formulary

Priority Health is a Michigan-based managed care organization offering commercial employer plans, individual/family marketplace plans, and Medicare Advantage products. Each product line maintains a separate formulary, meaning tadalafil's tier placement and coverage rules can differ substantially between a member's employer-sponsored PPO and their Medicare Advantage Part D plan.

Commercial Plan Formulary Tiers

On most Priority Health commercial formularies, drugs fall into five tiers:

• Tier 1: Preferred generics (lowest copay, often $0, $10)
• Tier 2: Non-preferred generics and preferred brands ($15, $45 copay)
• Tier 3: Non-preferred brands and specialty generics ($45, $75 copay)
• Tier 4: Specialty drugs (percentage coinsurance, often 20 to 33%)
• Tier 5: Excluded drugs or non-covered items

Generic tadalafil commonly sits at Tier 2 on Priority Health commercial plans when covered. Brand Cialis, if listed at all, typically lands at Tier 3. Some commercial plans place ED drugs in Tier 5 (excluded), which means no coverage regardless of documentation, unless prior authorization overrides that status. Checking the Summary of Benefits and Coverage (SBC) document provided by your employer is the fastest way to confirm your specific tier.

Medicare Advantage Part D Coverage

Under Medicare Part D rules, PDE5 inhibitors prescribed for ED are explicitly excluded by statute (Social Security Act Section 1860D-2(e)(2)(A)) (CMS Medicare Prescription Drug Benefit Manual). Priority Health Medicare Advantage plans follow federal law and do not cover tadalafil for ED under Part D. However, tadalafil 5 mg prescribed specifically for BPH may be covered under Part D on some plans, because BPH is not subject to the same statutory exclusion. Members should call the Priority Health Member Services number on their insurance card and ask specifically about tadalafil 5 mg for BPH under their plan's formulary (FDA tadalafil BPH approval).

Does Priority Health Require Prior Authorization for Cialis?

Prior authorization (PA) is required on most Priority Health plans for tadalafil, regardless of tier. The PA process exists to confirm the diagnosed indication, verify that contraindicated medications (particularly nitrates) are not co-prescribed, and, on some plans, document that a trial of sildenafil (generic Viagra) was attempted first.

What the Prior Authorization Form Typically Asks

Priority Health's PA reviewers generally request:

• The specific ICD-10 diagnosis code (ED vs. BPH vs. PAH)
• Serum testosterone level results if the provider suspects hypogonadism as a contributing factor
• A list of concomitant medications (especially nitrates and alpha-blockers, which interact with tadalafil)
• Documentation of clinical severity, such as the International Index of Erectile Function (IIEF) score for ED, which is validated in peer-reviewed literature (NCBI, IIEF validation study)
• Evidence of step therapy compliance if the plan requires a prior sildenafil trial

Step Therapy Requirements

Several Priority Health commercial plans require members to try at least one alternative PDE5 inhibitor before tadalafil is approved. Sildenafil (generic Viagra) is typically the first-line agent because its generic acquisition cost is lower. A published 2020 review in the Journal of Sexual Medicine found that approximately 35% of men who did not respond to sildenafil responded to tadalafil due to differing pharmacokinetic profiles, giving your prescriber clinical justification to document a legitimate step therapy failure (PubMed, PDE5 inhibitor comparison). That documentation can support a PA approval even when the insurer initially requires the step.

Clinical Evidence Supporting Tadalafil Coverage Arguments

When your prescriber submits a PA letter, they strengthen the case by citing the clinical evidence for tadalafil specifically. Here are the key trials that support medical necessity arguments.

IIEF Outcomes in Key ED Trials

The original Phase III tadalafil trials submitted to the FDA enrolled over 1,000 men with ED of varying etiologies. Tadalafil 20 mg improved IIEF erectile function domain scores by a mean of 7.2 points over placebo at 12 weeks (P<0.001) (PubMed, tadalafil Phase III trial). For the daily 5 mg dose studied in men with both ED and BPH, the IIEF score improvement was 5.1 points at 12 weeks versus 1.8 for placebo (P<0.001), demonstrating that even the low-dose regimen produces clinically significant benefit (PubMed, tadalafil daily dosing trial).

BPH Symptom Reduction Data

The LVHPJ-BPH trial and two additional Phase III studies showed that tadalafil 5 mg daily reduced the International Prostate Symptom Score (IPSS) by a mean of 3.8 points versus 1.7 for placebo at 12 weeks, a difference that meets the FDA's threshold for clinical meaningfulness (PubMed, tadalafil BPH IPSS trial). This level of evidence aligns with AUA guideline recommendations endorsing PDE5 inhibitors as an appropriate pharmacologic option for lower urinary tract symptoms secondary to BPH (AUA BPH Guidelines, 2022). The AUA guideline states: "Combination therapy with an alpha-blocker and a PDE5 inhibitor may be offered to patients with LUTS and ED." That direct guideline language is useful in a PA appeal letter.

Cardiovascular Safety Considerations

The ACC/AHA sexual activity guidelines note that PDE5 inhibitors are contraindicated only in patients taking concurrent nitrates, and that most men with stable cardiovascular disease can safely use them (AHA/ACC guidelines on sexual activity and cardiovascular disease). Communicating this to Priority Health's medical reviewers, when a patient has a documented cardiovascular history but is not on nitrates, can remove a common PA denial reason.

What to Do If Priority Health Denies Coverage

A denial is not the end of the road. Priority Health, like all insurers regulated under the ACA, must provide a written denial notice with the specific reason and instructions for appeal. The appeal process has two internal levels and, if both fail, an independent external review.

Step 1: Internal Appeal

Submit an internal appeal within 180 days of the denial notice (or the timeframe stated on your specific denial letter, whichever is shorter). Include:

• A letter of medical necessity from your prescriber on practice letterhead
• Copies of clinical notes documenting diagnosis, severity, and treatment rationale
• Relevant lab results (e.g., testosterone panel, PSA if BPH-related)
• Citations from peer-reviewed literature or clinical guidelines (AUA, AHA)

Step 2: External Independent Review

If the internal appeal fails, Michigan law and federal ACA rules give you the right to an independent external review by a certified third-party organization (CMS external review guidance). External reviewers overturn insurer denials at rates around 40 to 50% for medications with strong published evidence bases, according to CMS data on the external review process (CMS external review statistics).

Requesting a Formulary Exception

A formulary exception is different from a PA. It asks Priority Health to cover a drug that is otherwise excluded or at a lower cost-sharing tier. Formulary exceptions are available when a covered alternative would be medically inappropriate for a specific patient. Your prescriber documents why sildenafil or vardenafil would be inadequate, and Priority Health's pharmacy and therapeutics committee reviews the request within 72 hours (24 hours for expedited requests involving urgent clinical need) (CMS Part D exception and appeals process).

Cost Without Insurance and Discount Alternatives

If coverage is denied and appeals are exhausted, tadalafil remains one of the most affordable PDE5 inhibitors on the generic market.

Generic Tadalafil Pricing

Generic tadalafil became available in the United States in 2018 after Eli Lilly's patent exclusivity period ended (FDA, tadalafil patent expiration). At major pharmacy chains, 30 tablets of tadalafil 5 mg costs approximately $15, $40 with a GoodRx or similar discount coupon, compared to $400, $450 for brand-name Cialis. The FDA confirms bioequivalence of all approved generic tadalafil formulations to the brand (FDA bioequivalence standard).

Manufacturer and Patient Assistance Programs

Eli Lilly offers a patient assistance program for brand-name Cialis for uninsured or underinsured patients who meet income criteria. The income threshold and application process are managed through the Lilly Cares Foundation. Your prescriber's office can initiate the application, or you can visit LillyCares.com directly. Income eligibility typically falls at or below 400% of the federal poverty level.

Telehealth and Direct-to-Patient Pharmacies

Several telehealth platforms now offer tadalafil through direct-to-patient pharmacy models at fixed monthly prices, which can be lower than retail generic pricing even without insurance. The FDA regulates these pharmacies under the same standards as brick-and-mortar locations as long as they require a valid prescription from a licensed prescriber (FDA online pharmacy guidance). The FDA's BeSafeRx campaign specifically warns against non-prescription ED drug websites, which may dispense counterfeit tadalafil with inconsistent active ingredient concentrations.

Conditions That Improve the Odds of Priority Health Coverage Approval

Several clinical factors increase the likelihood that Priority Health approves tadalafil. Your prescriber should document these thoroughly in the PA submission.

Comorbid BPH With ED

When a patient carries both a BPH diagnosis and an ED diagnosis, the prescriber can document that tadalafil 5 mg daily addresses both conditions simultaneously, making alternative regimens less clinically appropriate. A 2012 study in European Urology confirmed that tadalafil 5 mg daily improved both IPSS and IIEF scores in men with comorbid BPH and ED, providing the dual-indication documentation that supports a PA argument (PubMed, tadalafil BPH plus ED).

Documented Sildenafil Intolerance or Failure

Sildenafil's shorter half-life (4 to 6 hours versus tadalafil's 17.5 hours) and higher rate of visual disturbances (approximately 3% for sildenafil versus <1% for tadalafil) give prescribers valid clinical reasons to bypass step therapy (PubMed, PDE5 inhibitor adverse effect comparison). Documenting a specific adverse effect or the patient's lifestyle requirement for a longer duration of action (e.g., shift worker with unpredictable schedule) strengthens the PA file.

Hypogonadism as a Contributing Cause

Low testosterone reduces nitric oxide synthase activity in penile tissue, which can blunt response to PDE5 inhibitors (PubMed, testosterone and PDE5 interaction). When ED is linked to documented hypogonadism (total testosterone <300 ng/dL by Endocrine Society criteria), the prescriber can frame tadalafil as part of a coordinated endocrine treatment plan rather than a standalone lifestyle medication. The Endocrine Society's 2018 clinical practice guideline on male hypogonadism explicitly endorses PDE5 inhibitors as adjunct therapy in hypogonadal men whose ED persists despite testosterone replacement (Endocrine Society, male hypogonadism guideline).

Understanding the Difference Between Commercial and Medicare Advantage Rules

The coverage rules for tadalafil diverge significantly based on the type of Priority Health plan. Getting this distinction wrong leads to wasted appeals.

Commercial Plans Follow State and Employer Rules

Michigan state law does not mandate coverage of ED medications, meaning fully insured Priority Health commercial plans may legally exclude them. Self-funded employer plans governed by ERISA follow the plan document their employer designed, which may or may not include ED drugs. The first step for any commercial plan member is pulling the plan's Summary of Benefits and Coverage and searching for "erectile dysfunction" or "PDE5 inhibitor" in the exclusions section.

Medicare Advantage Follows Federal Statute

As noted above, the federal statutory exclusion of ED drugs from Medicare Part D coverage applies to all Medicare Advantage plans, including Priority Health's. No amount of PA documentation or appeals will override a statutory exclusion under Part D. BPH, however, remains coverable. The CMS Medicare Prescription Drug Benefit Manual at Chapter 6 outlines which drug categories are excluded by statute and which may be covered at plan discretion (CMS, Medicare Part D excluded drug categories).

Marketplace (ACA Exchange) Plans

Individual and family plans purchased through HealthCare.gov or the Michigan marketplace follow ACA essential health benefit rules. ED drugs are not classified as an essential health benefit, so exclusion is permitted. However, some Priority Health silver and gold marketplace plans do include generic tadalafil on their formularies as a voluntary benefit. Checking the plan's formulary file on HealthCare.gov before enrollment is the only reliable way to confirm coverage.

How to Check Your Specific Priority Health Formulary

The fastest path to an accurate answer:

1. Log into your Priority Health member portal at priorityhealth.com and manage to "Drug Coverage" or "Formulary."
2. Search for "tadalafil" (generic) and "Cialis" (brand) separately, as they may have different tier placements.
3. Note whether a PA icon or step therapy icon appears next to either entry.
4. Call the pharmacy benefits number on the back of your insurance card and ask the representative to confirm tier, PA requirements, and any quantity limits (Priority Health commonly limits daily tadalafil to a 90-day supply per dispensing for cost management).
5. Ask your prescriber's office to run an electronic benefit investigation (e-BI) through their EMR system, which pulls real-time formulary data and PA criteria directly from Priority Health's payer database.

Your pharmacist can also run a real-time eligibility check at the point of sale, which shows your expected copay and flags any PA holds before you pay.